Hemodynamic and arrhythmogenic effects of cocaine in hypertensive individuals

Journal of Clinical Hypertension

Volumn 13, Issue 10, 2011, Pages 744-749

  Secemsky, Eric ^a   Lange, David ^a   Waters, David D ^a   Goldschlager, Nora F ^a   Hsue, Priscilla Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; COCAINE; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; THIAZIDE DIURETIC AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARRHYTHMOGENESIS; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE CUFF; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; DRUG EFFECT; ECTOPIA CORDIS; ELECTROCARDIOGRAM; FEMALE; HEART HEMODYNAMICS; HEART RATE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA;

ADULT; ANTIHYPERTENSIVE AGENTS; AORTIC DISEASES; ARRHYTHMIAS, CARDIAC; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; COCAINE; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; VASOCONSTRICTOR AGENTS;

EID: 80053565409     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2011.00520.x     Document Type: Article

References (40)

1. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. National Household Survey on Drug Abuse: Main Findings.Rockville, MD: Department of Health and Human Services; 2010.
2. World Drug Report 2007. Report no. E.07.XI.5, United Nations Office on Drugs and Crime. Vienna, Austria: United Nations Publication; 2007.
3. Drug Abuse Warning Network 2005. National estimates of drug-related emergency department visits. Accessed November 11, 2010.
4. Menon DV, Wang Z, Fadel PJ. Central sympatholysis as a novel countermeasure for cocaine-induced sympathetic activation and vasoconstriction in humans. J Am Coll Cardiol. 2007;50:626-633.
5. Chakko S. Arrhythmias associated with cocaine abuse. Card Electrophysiol Rev. 2002;6:168-169.
6. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med. 2001;345:351-358.
7. Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003; 21: 1983-1992.
8. Cutler JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008;52:818.
9. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043-2050.
10. Brecklin CS, Gopaniuk-Folga A, Kravetz T, et al. Prevalence of hypertension in chronic cocaine users. Am J Hypertens. 1998;11:1279.
11. Braun BL, Murray DM, Sidney S. Lifetime cocaine use and cardiovascular characteristics among young adults: the CARDIA study. Am J Public Health. 1997;87:629-634.
12. Hollander JE, Shih RD, Hoffman RS, et al. Predictors of coronary artery disease in patients with cocaine-associated myocardial infarction. Cocaine-Associated Myocardial Infarction (CAMI) Study Group. Am J Med. 1997;102:158-163.
13. Hsue PY, Salinas CL, Bolger AF, et al. Acute aortic dissection related to crack cocaine. Circulation. 2002;105:1592-1595.
14. Thakur V, Godley C, Weed S, et al. Case reports: cocaine-associated accelerated hypertension and renal failure. Am J Med Sci. 1996;312:295-298.
15. Dunea G, Arruda JA, Bakir AA, et al. Role of cocaine in end-stage renal disease in some hypertensive African Americans. Am J Nephrol. 1995;15:5-9.
16. Qureshi AI, Mohammad Y, Suri MF, et al. Cocaine use and hypertension are major risk factors for intracerebral hemorrhage in young African Americans. Ethn Dis. 2001;11:311-319.
17. Broderick JP, Viscoli CM, Brott T, et al.; Hemorrhagic Stroke Project Investigators. Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable. Stroke. 2003;34:1375-1381.
18. Tuncel M, Wang Z, Arbique D, et al. Mechanism of the blood pressure-raising effect of cocaine in humans. Circulation. 2002;105:1054-1059.
19. Jacobsen TN, Grayburn PA, Snyder RWI, et al. Effects of intranasal cocaine on sympathetic nerve discharge in humans. J Clin Invest. 1997;99:628-634.
20. Vongpatanasin W, Mansour Y, Chavoshan B, et al. Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation. 1999;100:497-502.
21. Eisenberg MJ, Mendelson J, Evans GT Jr, et al. Left ventricular function immediately after intravenous cocaine: a quantitative two-dimensional echocardiographic study. J Am Coll Cardiol. 1993;22:1581-1586.
22. Benzaquen BS, Cohen V, Eisenberg MJ. Effects of cocaine on the coronary arteries. Am Heart J. 2001;142:402-410.
23. Lange RA, Cigarroa RG, Flores ED, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med. 1990;112:897-903.
24. Lange RA, Cigarroa RG, Yancy CW Jr, et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med. 1989;321:1557-1562.
25. Vezina P. Sensitization, drug addiction and psychopathology in animals and humans. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:1553-1555.
26. Ohmori T, Abekawa T, Ito K, Koyama T. Context determines the type of sensitized behavior: a brief review and a hypothesis on the role of environment in behavioural sensitization. Behav Pharmacol. 2000;11:211-221.
27. Tella SR, Schindler CW, Goldberg SR. Rapid sensitization to the cardiovascular effects of cocaine in rats. Eur J Pharmacol. 1991;194:119-122.
28. Reed SC, Haney M, Evans SM, et al. Cardiovascular and subjective effects of repeated smoked cocaine administration in experienced cocaine users. Drug Alcohol Depend. 2009;102:102-107.
29. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension. 1989;14:177-183.
30. Esler M, Jennings G, Biviano B, et al. Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J Cardiovasc Pharmacol. 1986;8:S39-S43.
31. Esler M, Jennings G, Lambert G. Noradrenaline release and the pathophysiology of primary human hypertension. Am J Hypertens. 1989;2:140S-146S.
32. Castellano M, Rossi F, Giacche M, et al. Beta(2)-adrenergic receptor gene polymorphism, age, and cardiovascular phenotypes. Hypertension. 2003;41:361-367.
33. Oliver E, Martí D, Montó F, et al. The impact of alpha1-adrenoceptors up-regulation accompanied by the impairment of beta-adrenergic vasodilatation in hypertension. J Pharmacol Exp Ther. 2009;328:982-990.
34. Hoffman RS. Treatment of patients with cocaine-induced arrhythmias: bringing the bench to the bedside. Br J Clin Pharmacol. 2010;69:448-457.
35. Hsue PY, McManus D, Selby V, et al. Cardiac arrest in patients who smoke crack cocaine. Am J Cardiol. 2007;99:822-824.
36. O'Leary ME, Hancox JC. Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated arrhythmias. Br J Clin Pharmacol. 2010;69:427-442.
37. Littmann L, Monroe MH, Svenson RH. Brugada-type electrocardiographic pattern induced by cocaine. Mayo Clin Proc. 2000;75:845.
38. Om A, Ellahham S, Vetrovec GW, et al. Left ventricular hypertrophy in normotensive cocaine users. Am Heart J. 1993;125:1441-1443.
39. Chokshi SK, Moore R, Pandian NG, Isner JM. Reversible cardiomyopathy associated with cocaine intoxication. Ann Intern Med. 1989;111:1039-1040.
40. Bertolet BD, Freund G, Martin CA, et al. Unrecognized left ventricular dysfunction in an apparently healthy cocaine abuse population. Clin Cardiol. 1990;13:323-328.